Delivery Order N6264518D5059-N6264520F0037
Award Date 12/13/19
Potential Completion Date 12/31/19
Potential Value $3K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
WPAFB, OH 45433, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Charles River Laboratories, Inc., doing business as Charles River, has been awarded a $354 firm fixed price delivery order for SPRAGUE DAWLEY RAT STRAIN CODE 400 by the Department of the Navy Bureau of Medicine and Surgery. The contract has no set-aside designation and calls for delivery of the specified rat strain to a location in Wilmington, Massachusetts by January 6, 2020. The Bureau of Medicine and Surgery supports the Navy and Marine Corps through programs such as medical research and...
- Charles River Laboratories, Inc., doing business as Charles River, has been awarded a $3,018.67 firm fixed price delivery order by the Department of the Navy Bureau of Medicine and Surgery for the procurement of Sprague Dawley rat strain code 400. The contract has no set-aside designation and calls for delivery to be completed by September 20, 2021 at the place of performance in Wilmington, Massachusetts. The Bureau of Medicine and Surgery supports the Navy through programs such as biomedical...
- Charles River Laboratories, Inc. has been awarded a firm fixed price contract valued at four thousand one hundred thirty dollars and fifty-five cents ($4,130.55) by the Department of the Army Medical Command to provide RAT SPRAGUE DAWLEY CD MALE. The contract does not contain any set aside provisions. Performance will occur at Charles River's facility located in Wilmington, Massachusetts and must be completed by November 26, 2018. Charles River is a manufacturer and provider of research models...
- This is a contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Charles River Laboratories, Inc. (doing business as Charles River) for the development and maintenance of a multigenotypic aged rat colony. The contract has a potential value of $1,558,112.20 and is a cost plus fixed fee delivery order with a completion date of December 19, 2018. Charles River is a for-profit organization that manufactures research...
- This is a federal contract award by the Food and Drug Administration (FDA), a civilian agency, to Charles River Laboratories, Inc. (doing business as Charles River) to provide 186 003 female Wistar rats. The contract has a ceiling value of $11,033.52 and was awarded on December 20, 2024, with an ultimate completion date of April 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. Charles River is a global contract...
- Charles River Laboratories, Inc., doing business as Charles River, has been awarded a delivery order valued at $3.8 million by the National Institutes of Health's National Institute on Aging to provide development and maintenance services for a multigenotypic aged rat colony. The cost-plus-fixed-fee contract runs from January 20, 2021 through January 19, 2022. As the prime contractor, Charles River will leverage its expertise in laboratory animal research and care to support the National...
- This is a federal contract award to Charles River Laboratories, Inc. (doing business as Charles River) by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $123,082.81, is for the development and maintenance of a multigenotypic aged rat colony to support aging research initiatives. The contract has a period of performance through December 19, 2017 and is a cost-plus-fixed-fee delivery order. This contract is...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed-price purchase order valued at $104,664 to Gentronix LIMITED (UEI: NCW6AS93ASL6) on July 11, 2023, for a project titled "Big Blue Rats." The contract, which was not issued under any small business set-aside, is scheduled for completion by June 1, 2024, and will be performed at the contractor's facility in Germantown, New York. As a civilian agency contract, this award supports the FDA's mission, which encompasses...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a purchase order to Med Associates, Inc. for rat testing chambers and components on August 28, 2025, with a ceiling value of $22.4K and a firm fixed price structure. The contract, which has no set-aside designation, is scheduled for completion by December 28, 2025, and will be performed in San Diego, California. Med Associates, Inc., a woman-owned small business manufacturer based in Fairfax, Vermont, specializes...
- The Defense Health Agency awarded a $10,434 firm fixed-price call order to Harvard Bioscience Inc., operating as Data Sciences International, on December 29, 2022, for a Whole Body Plethysmography (WBP) Conscious Rat with Tower system. This award represents a task order under Harvard Bioscience's single-award Blanket Purchase Agreement with the Defense Health Agency, valued at $4.8 million and effective through May 2027. The BPA was established to provide specialized biomedical research...
- N6264518D5059Indefinite Delivery Contract
- N6264518D5059-N6264520F0037Delivery Order
LONG-EVANS RATS, MALE, 151-175G
Posted 12/11/19
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NAMRU-D IDIQ MICE, RODENTS AND GERBILS | ADVFY18RD00005 | Department of the Navy Bureau of Medicine and Surgery | Award Notice 1/1 | 1/3/18, 4:26 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/11/19 |